Monoaminergic neuropathology in Alzheimer’s disease

Title
Monoaminergic neuropathology in Alzheimer’s disease
Authors
Keywords
5-hydroxytryptamine (serotonin), Alzheimer’s disease, Amyloid beta (Aβ) peptide, Blood-brain barrier, Cerebrospinal fluid, Epigenetics, Locus coeruleus, Metals, Monoamines, Neurofibrillary degeneration, Non-cognitive symptoms, Nucleus raphe dorsalis, Phosphorylation, Sleep-wake cycle, Tau protein
Journal
PROGRESS IN NEUROBIOLOGY
Volume 151, Issue -, Pages 101-138
Publisher
Elsevier BV
Online
2016-04-13
DOI
10.1016/j.pneurobio.2016.04.001

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started